The biotech and med-tech sectors report significant financial and managerial movements. PCI Pharma Services secured private equity funding valuing the CDMO at $10 billion, backed by Bain Capital, Mubadala, and others, targeting expansion in drug manufacturing capacity, including PROTACs and ADCs. Zimmer Biomet announced acquisition of orthopedic robotics firm Monogram Technologies for approximately $168 million. Several new executive appointments occurred across biopharma and med-tech firms, reflecting ongoing restructuring and growth strategies amid evolving market demands.